BIRTCHER CONSIDERING SALE OF COMPANY, OTHER "STRATEGIC ALTERNATIVES"
This article was originally published in The Gray Sheet
Executive Summary
Birtcher Medical is evaluating several "strategic alternatives," including finding a buyer for the firm, as part of an effort to shore up its sagging financial performance. On April 14, Birtcher said it is looking into "a possible sale of the company or of various operating assets, as well as a possible capital infusion, either from foreign investors or a loan from other sources."